HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Soamnauth Misir Selected Research

Colesevelam Hydrochloride (Welchol)

5/2013Colesevelam improved lipoprotein particle subclasses in patients with prediabetes and primary hyperlipidaemia.
7/2012Clinical effects of colesevelam in Hispanic subjects with primary hyperlipidemia and prediabetes.
7/2012Initial combination therapy with metformin plus colesevelam in drug-naïve Hispanic patients with early type 2 diabetes.
7/2012Initial combination therapy with metformin plus colesevelam improves lipoprotein particles in patients with early type 2 diabetes mellitus.
7/2010Initial combination therapy with metformin and colesevelam for achievement of glycemic and lipid goals in early type 2 diabetes.
7/2010Colesevelam hydrochloride to treat hypercholesterolemia and improve glycemia in prediabetes: a randomized, prospective study.
4/2010The effect of colesevelam hydrochloride on insulin sensitivity and secretion in patients with type 2 diabetes: a pilot study.
2/2010Colesevelam hydrochloride: efficacy and safety in pediatric subjects with heterozygous familial hypercholesterolemia.
1/2010A 50-week extension study on the safety and efficacy of colesevelam in adults with primary hypercholesterolemia.
9/2009Rationale and design of a clinical trial to evaluate metformin and colesevelam HCl as first-line therapy in type 2 diabetes and colesevelam HCl in prediabetes.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Soamnauth Misir Research Topics

Disease

7Type 2 Diabetes Mellitus (MODY)
07/2012 - 06/2009
4Prediabetic State (Prediabetes)
05/2013 - 09/2009
4Hypercholesterolemia
07/2010 - 06/2009
2Hyperlipidemias (Hyperlipidemia)
07/2012 - 07/2012
1Anaplastic Thyroid Carcinoma
01/2021
1Thyroid Neoplasms (Thyroid Cancer)
01/2021
1Breast Neoplasms (Breast Cancer)
01/2020
1Neutropenia
01/2020
1Hepatocellular Carcinoma (Hepatoma)
01/2020
1Insulin Resistance
04/2010
1Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
02/2010
1Hyperglycemia
09/2009
1Glucose Intolerance
09/2009

Drug/Important Bio-Agent (IBA)

11Colesevelam Hydrochloride (Welchol)FDA Link
05/2013 - 06/2009
7oxidized low density lipoproteinIBA
05/2013 - 06/2009
7LDL CholesterolIBA
05/2013 - 06/2009
5Glucose (Dextrose)FDA LinkGeneric
05/2013 - 09/2009
4LipidsIBA
05/2013 - 09/2009
4Metformin (Glucophage)FDA LinkGeneric
07/2012 - 09/2009
3Lipoproteins (Lipoprotein)IBA
05/2013 - 09/2009
3Bile Acids and Salts (Bile Acids)IBA
07/2012 - 06/2009
2lenvatinibIBA
01/2021 - 01/2020
2Triglycerides (Triacylglycerol)IBA
05/2013 - 07/2010
2Pharmaceutical PreparationsIBA
07/2012 - 09/2009
2Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
09/2009 - 06/2009
1eribulinFDA Link
01/2020
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2020
1Epidermal Growth Factor (EGF)IBA
01/2020
1LDL Lipoproteins (beta Lipoproteins)IBA
07/2012
1Hemoglobins (Hemoglobin)IBA
07/2010
1Insulin (Novolin)FDA Link
04/2010
1HDL CholesterolIBA
01/2010

Therapy/Procedure

5Therapeutics
01/2020 - 09/2009
2Drug Therapy (Chemotherapy)
01/2020 - 09/2009